Цели, которые мы считаем Налаштування

[-=Vzhik=-]

Здесь будет выкладываться информация относительно заданий, которые находятся на данный момент в работе.

Find-a-Drug searched for drugs to fight major diseases. The project studied cancer, bioterrorism diseases, respiratory diseases, multiple sclerosis, HIV (AIDS), Malaria, and CJD, as well as studying the human proteome in general, and the methodology for testing potential drug compunds against disease protein targets. The non-project was run by Treweren Consultants, creators of the THINK screensaver.
On June 30, 2003, the project announced that it successfully found some potential cancer-inhibiting drugs. After testing over 500 million molecules, it produced a set of candidates. 39 candidates were tested in a laboratory, and 7 of those (20%) showed the desired anti-cancer properties. Only 2-3% were expected to show the desired properties. On November 12, 2003, the project announced that it had found growth inhibitors for 5 anti-cancer protein targets. "42 of the 200 molecules tested [so far] showed the desired anti-cancer properties." On March 22, 2004, the project announced that it had "found more molecules which inhibit the growth of cancer cells," and had now discovered "growth inhibitors for 7 anti-cancer protein targets." On April 16, 2004, the project announced that it had found 18 molecules which inhibit the growth of HIV protease, an AIDS protein. More of its cancer-fighting drugs were confirmed to be effective in laboratory tests as of July 2, 2004. On March 14, 2005, the project published a list of 1,279 molecules, tested in a lab, which showed desired anti-cancer properties. These molecules were discovered by 626 project volunteers.

The project ended on December 16, 2005. Questions about the project's closing are answered in the project FAQ. The project's discussion forum may also remain active for a while.

[Arbalet]

1M2G-Q1 | Cancer | 4097 jobs
Регулятор передачи сигналов 2 (Sir2) может дезактивировать p53 (белок супрессора опухоли), который является нежелательным в опухолях. Ингибиторы Sir2 имеют потенциал как новые антираковые препараты.

Жабки считаются долго, но зато очень много хитов и конформеров!
4-DEC-05 15:51 Found 121: m510#36-25(61)
4-DEC-05 16:07 Found 122: m510#36-21(10)
4-DEC-05 16:30 Found 123: m510#36-14(51)
4-DEC-05 16:35 Found 124: m510#36-13(1)
4-DEC-05 16:41 Found 125: m510#36-12(14)